Hence, the objective of this meta-analysis was to comprehensively investigate the effect of PCSK9 inhibitor combined with statins compared to statin-only treatment in terms of altering lipid profile as well as evaluating the effect of lipid profile changes by evaluating the coronary plaque phenotype on patients following acute coronary syndrome. The gene discussed is PCSK9; the disease is acute coronary syndrome.